Back to top
more

UnitedHealth Group (UNH)

(Real Time Quote from BATS)

$566.71 USD

566.71
598,387

+0.68 (0.12%)

Updated Oct 18, 2024 09:58 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (233 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Should Invesco Dividend Achievers ETF (PFM) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for PFM

Company News for Oct 17, 2022

by Zacks Equity Research

Companies in The News Are: JPM,UNH,C,WFC

UnitedHealth (UNH) Beats on Q3 Earnings, Ups 2022 EPS View

by Zacks Equity Research

UnitedHealth's (UNH) third-quarter results were supported by membership growth and strong Optum performance.

UnitedHealth Group (UNH) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

UnitedHealth (UNH) delivered earnings and revenue surprises of 6.24% and 0.21%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

The Zacks Analyst Blog Highlights Morgan Stanley, UnitedHealth Group, Lockheed Martin, United Airlines and First Horizon

by Zacks Equity Research

Morgan Stanley, UnitedHealth Group, Lockheed Martin, United Airlines and First Horizon are included in this Analyst Blog.

Nalak Das headshot

5 Large-Cap Stocks Likely to Beat on Q3 Earnings

by Nalak Das

Five large-cap companies will report third-quarter 2022 earnings within the next seven days. These are: UNH, UAL, MS, LMT and FHN.

Here's How Investors Can Find Strong Medical Stocks with the Zacks ESP Screener

by Zacks Equity Research

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Mayur Thaker headshot

Stocks Attempt Rally on Hope for Upbeat Earnings, Unlikely to Last for Long

by Mayur Thaker

Market may be due for a breather, but primary trend indicates lower

Will UnitedHealth Group (UNH) Beat Q3 Earnings Estimates?

by Zacks Equity Research

UnitedHealth Group's (UNH) third-quarter results are likely to benefit from higher premiums and membership growth in its UnitedHealthcare unit, partly offset by elevated technology investment costs.

Sweta Killa headshot

Dow ETFs in Focus Ahead of Q3 Earnings

by Sweta Killa

After the worst first nine months of 2022, the Dow Jones Industrial Average showed some stability at the start of the fourth quarter.

UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, UnitedHealth Group (UNH) closed at $498.86, marking a -1.19% move from the previous day.

Wall Street Waits for Q3 2022 Earnings to Kick Off

by Zacks Equity Research

Wall Street Waits for Q3 2022 Earnings to Kick Off.

Mark Vickery headshot

Big Week for Data, Earnings Starts Quiet

by Mark Vickery

The big news for the week will be along two paths: CPI data for September and the start of Q3 earnings season.

UnitedHealth Group (UNH) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

UnitedHealth (UNH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is Trending Stock UnitedHealth Group Incorporated (UNH) a Buy Now?

by Zacks Equity Research

UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Is SPDR MSCI USA StrategicFactors ETF (QUS) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for QUS

Zacks Market Edge Highlights: ExxonMobil, Meta Platforms, UnitedHealth Group, Biogen and NVIDIA

by Zacks Equity Research

ExxonMobil, Meta Platforms, UnitedHealth Group, Biogen and NVIDIA are part of the Zacks Market Edge article.

Tracey Ryniec headshot

Should You Sell Your FANGMAN Stocks?

by Tracey Ryniec

Tracey and Kevin discuss the rocky 2022 stock market and the future of growth stocks.

UnitedHealth (UNH) Grows on Optum Strength, Cost Woes Stay

by Zacks Equity Research

UnitedHealth's (UNH) health service business, Optum, is becoming increasingly valuable and is crucial to the company's diversification strategy.

UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know

by Zacks Equity Research

In the latest trading session, UnitedHealth Group (UNH) closed at $523.17, marking a +1.49% move from the previous day.

Why UnitedHealth (UNH) Could Beat Earnings Estimates Again

by Zacks Equity Research

UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Cigna's (CI) New Pathwell Suite to Boost Efficiency, Lower Cost

by Zacks Equity Research

Cigna (CI) expects to bump up its Pathwell suite's availability throughout the next year.

    Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?

    by Zacks Equity Research

    Smart Beta ETF report for VIG

    How Investors Can Grab Better Returns for Medical Using the Zacks ESP Screener

    by Zacks Equity Research

    Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

    Should Vanguard Value ETF (VTV) Be on Your Investing Radar?

    by Zacks Equity Research

    Style Box ETF report for VTV